M&T Bank Corp Cuts Stake in Danaher Corporation $DHR

M&T Bank Corp lessened its holdings in Danaher Corporation (NYSE:DHR) by 78.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 92,179 shares of the conglomerate’s stock after selling 340,604 shares during the quarter. M&T Bank Corp’s holdings in Danaher were worth $21,102,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Capital International Investors increased its holdings in shares of Danaher by 1.9% in the third quarter. Capital International Investors now owns 16,758,240 shares of the conglomerate’s stock worth $3,318,926,000 after buying an additional 312,951 shares during the period. Generation Investment Management LLP lifted its stake in shares of Danaher by 34.0% in the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after acquiring an additional 1,689,020 shares during the last quarter. Legal & General Group Plc boosted its holdings in Danaher by 5.0% during the 3rd quarter. Legal & General Group Plc now owns 4,452,118 shares of the conglomerate’s stock valued at $882,677,000 after acquiring an additional 211,053 shares during the period. Fisher Asset Management LLC grew its position in Danaher by 0.7% during the 3rd quarter. Fisher Asset Management LLC now owns 4,369,219 shares of the conglomerate’s stock worth $866,241,000 after acquiring an additional 28,583 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in Danaher by 104.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher News Roundup

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Q1 EPS beat and slight raise to FY EPS range — Danaher beat non‑GAAP EPS estimates ($2.06 vs. consensus) and nudged full‑year adjusted EPS guidance higher, which supports earnings visibility. Earnings Call Highlights
• Positive Sentiment: Bioprocessing momentum and M&A strategy remain drivers — management highlighted strength in bioprocessing and the acquisition pipeline as long‑term growth levers. Q1 Deep Dive
• Neutral Sentiment: Large euro‑denominated senior‑notes offering (~€2.98B net proceeds) — the deal finances operations and transactions but increases liabilities; market reaction depends on how proceeds are used. Notes Offering
• Neutral Sentiment: Masimo acquisition: longer‑term optionality vs. near‑term integration/earnings pressure — analysts note the deal adds strategic upside but may weigh on near‑term returns and capital allocation. Masimo Analysis
• Negative Sentiment: $172.5M shareholder settlement over post‑pandemic demand disclosures — a material cash charge and reputational headwind that increases near‑term litigation/expense risk. Settlement Report
• Negative Sentiment: Revenue miss and Diagnostics softness weighed on the print — core revenue growth was modest and Diagnostics showed weakness (lighter respiratory season at Cepheid), which undercut the EPS beat. Revenue/Segment Notes
• Negative Sentiment: Multiple analyst price‑target cuts (Morgan Stanley, JPMorgan, Wells Fargo, Guggenheim, UBS among others) — downgrades and lower targets increase downside pressure and reduce near‑term analyst support. Morgan Stanley PT Cut

Danaher Price Performance

Shares of DHR stock opened at $178.72 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a fifty-two week low of $175.00 and a fifty-two week high of $242.80. The firm has a market cap of $126.49 billion, a P/E ratio of 34.57, a P/E/G ratio of 2.50 and a beta of 0.95. The business’s 50 day moving average price is $196.45 and its 200-day moving average price is $214.10.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, April 21st. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.88 earnings per share. Danaher has set its FY 2026 guidance at 8.350-8.550 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 8.4 earnings per share for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. This is a positive change from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio is 30.95%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on DHR shares. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. TD Cowen cut their target price on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a report on Wednesday. Morgan Stanley decreased their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday. Evercore increased their price target on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a report on Tuesday. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $242.45.

Insider Buying and Selling at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 10.80% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.